AKSHAY DEOTARE: Open Payments
NPI 1881148328 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 9 payments from 6 companies in 2025. Trend: 2023 $244 · 2024 $299 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $83 |
| ABBVIE INC. | 1 | $34 |
| Melinta Therapeutics, LLC | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: KEYTRUDA, VENCLEXTA, Rezzayo, ZERBAXA, XIFAXAN, INLYTA, JARDIANCE.
Industry payments across OH — which companies pay providers there.
